Table 4 Odds ratios for exposures within the COVID-19 cohort for patients who had compared to those who did not have a non-elective hospitalization on or after June 1, 2020
Exposure (3-month lookback unless otherwise indicated) | Odds Ratio (95% CI) | p value |
|---|---|---|
In-person visit to a PCP (above median) | 1.36 (1.10–1.69) | 0.0041 |
Virtual visit to a PCP (above median) | 1.85 (1.49–2.30) | < 0.0001 |
In-person visit to a specialist (above median) | 1.66 (1.34–2.07) | < 0.0001 |
Virtual visit to a specialist (above median) | 1.12 (0.79–1.58) | 0.54 |
Radiation | 1.05 (0.74–1.49) | 0.80 |
Chemotherapy | 1.46 (1.16–1.83) | 0.0012 |
1 or more prior non-elective hospitalization (from time of initial cancer diagnosis up to June 1, 2020) | 2.00 (1.62–2.48) | < 0.0001 |
Metastatic cancer stage (at diagnosis) | 2.00 (1.41–2.82) | 0.0001 |